SEHK:1681Pharmaceuticals
Consun Pharmaceutical Group (SEHK:1681) Valuation Check After Expanded HK$300 Million Share Buyback Plan
Consun Pharmaceutical Group expands buyback plan
Consun Pharmaceutical Group (SEHK:1681) has expanded its existing share repurchase plan, adding HK$100 million to the programme to allow for up to HK$300 million in potential buybacks funded from existing cash resources.
See our latest analysis for Consun Pharmaceutical Group.
The increased buyback plan comes after a strong run in the shares, with a 15.54% 1 month share price return and a 20.23% 3 month share price return helping support a very...